Scribd
Upload
5 views

Business Project

Uploaded by

Pyali Patra
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
5 views

Business Project

Uploaded by

Pyali Patra
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 10

SUN PHARMA

DONE BY-

ANANT SINGH
PYALI PATRA
PRADEEP GUPTA
Overview

01 02 03 04
Introduction Economic Analysis Industry Analysis Company Analysis

06 07
DCF Recommendations
Introduction
Sun Pharmaceutical Industries
Limited is an Indian multinational
pharmaceutical company
headquartered in Mumbai, that
manufactures and sells
pharmaceutical formulations and
active pharmaceutical ingredients in
more than 100 countries across the
globe.
Economic Analysis

Key Economic Indicators

• Market Size: 3.14 trillion INR

• Growth Rate: 15.6% per


annum
Economic Analysis

Global Economy Currency Fluctuations Inflationary Pressures

• A robust global economy • Sun Pharma has global • Rising input costs due to
drives healthcare operations, making it inflation can dent Sun
spending, benefitting vulnerable to currency Pharma's profitability
Sun Pharma. fluctuations. • Its ability to pass on these
• However, economic • Appreciation of the Indian costs through price hikes
downturns can rupee against key export depends on market
currencies like the US dollar dynamics and pricing
negatively impact
can squeeze its export power.
demand.
margins.
Industry Analysis
Company Analysis

Financial Performance Product Portfolio Diversification


Sun Pharma boasts a strong financial Diversification across generics,
performance with consistent revenue branded generics, complex generics,
growth, healthy profitability, and a and specialty drugs mitigates risks
manageable debt-to-equity ratio. associated with individual products or
markets.

R&D Focus Management Expertise

Sun Pharma's investments in R&D fuel Sun Pharma's experienced and


its pipeline of new drugs and maintain competent management team has a
its competitive edge. proven track record of success in
navigating market challenges and
driving growth.
R
A
T
I
O

A
N
A
L
Y
S
I
S
DCF Valuation
The company has shown consistent revenue
growth and increasing profitability in recent years. Recommendations

Sun pharma offers a wide range of generic &


specialty medicine, which
Helps to mitigate rise & reduce dependence on
any single product.

The company has a strong and experienced


management team with a deep understanding of
the pharmaceutical industry.

The sun pharma is actively investing in research


and development which could lead to future
growth opportunity

You might also like